Vertex Pharmaceuticals Incorporated and Alpine Immune Sciences, Inc. a biotechnology company focused on discovering and developing innovative, protein-based immunotherapies, announced that the companies have entered into a definitive agreement under which Vertex will acquire Alpine for $65 per share or approximately $4.9 billion in cash
Immunology, the immune system and immune-mediated diseases.
Merck Inc., and Immune Design announced that the companies have entered into a definitive agreement under which Merck, through a...
Bio Products Laboratory announced that the FDA has approved Gammaplex 10% (immune globulin intravenous [human], 10% liquid) for the treatment...
Biosimilars can be effective in reducing the burden of immune-mediated inflammatory diseases (IMIDs).
ADMA Biologics has submitted its Biologics License Application to the FDA, seeking marketing authorisation for RI 002 for treatment of...
In this article, we review the main immunological mechanisms involved in MS pathogenesis.
Inflammation and metabolic dysfunction are hallmarks of nonalcoholic steatohepatitis (NASH), which is one of the fastest?
Swedish Orphan Biovitrum AB (publ) (Sobi) (STO:SOBI) announces that the European Commission (EC) has approved an extension of the indication for Doptelet (avatrombopag) to include the treatment of primary chronic immune thrombocytopenia (ITP) in adult patients who are refractory to other treatments (e.g. corticosteroids, immunoglobulins) in all European Union (EU) member states.
The Blood Products Advisory Committee (BPAC) of the FDA voted 15-1 that HyQ via (subcutaneous immune globulin with recombinant human...